DEUTSCHE BANK AG\ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,237
-72.5%
24,020
-71.9%
0.00%
Q2 2021$335,000
+161.7%
85,566
+167.0%
0.00%
Q1 2021$128,000
+70.7%
32,052
-1.4%
0.00%
Q4 2020$75,000
-50.7%
32,492
+23.0%
0.00%
Q3 2020$152,000
-5.0%
26,418
+21.3%
0.00%
Q2 2020$160,000
+66.7%
21,785
-6.0%
0.00%
Q4 2019$96,000
+190.9%
23,165
+125.6%
0.00%
Q3 2019$33,000
+450.0%
10,269
+208.3%
0.00%
Q2 2019$6,000
-98.7%
3,331
-98.7%
0.00%
Q1 2019$454,000
+263.2%
257,262
+394.4%
0.00%
Q4 2018$125,000
-95.5%
52,032
-89.5%
0.00%
-100.0%
Q3 2018$2,795,000
-40.9%
493,427
-18.6%
0.00%0.0%
Q2 2018$4,727,000
+126.3%
606,245
+105.0%
0.00%0.0%
Q1 2018$2,089,000
+0.3%
295,722
+40.1%
0.00%0.0%
Q4 2017$2,082,000
+18.9%
211,101
+3.2%
0.00%0.0%
Q3 2017$1,751,000
-18.8%
204,494
-0.6%
0.00%
-50.0%
Q2 2017$2,157,000205,8260.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,252,892$10,930,0004.97%
GLOBEFLEX CAPITAL L P 1,397,770$4,697,0001.02%
BVF INC/IL 6,631,051$22,280,0000.87%
EcoR1 Capital, LLC 6,082,200$20,436,0000.71%
Ikarian Capital, LLC 1,105,082$3,715,0000.26%
CHI Advisors LLC 233,510$785,0000.23%
DCF Advisers, LLC 141,701$476,0000.21%
Artal Group S.A. 2,500,000$8,400,0000.19%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,577,0000.07%
ACADIAN ASSET MANAGEMENT LLC 1,903,162$6,394,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders